Brief: Devin Holden Divests SEK 1.4 Million Worth Of Hansa Biopharma Shares
14/09/2026 11:16
BRIEF-Devin Holden Divests SEK 1.4 Million Worth Of Hansa Biopharma Shares Sept 14 (Reuters) - Finansinspektionen:
DEVIN HOLDEN, IDENTIFIED AS PERSON SUBJECT TO NOTIFICATION OBLIGATIONS, DIVESTS SHARES IN HANSA BIOPHARMA ON THURSDAY
33,704 SHARES OF HANSA BIOPHARMA AB DISPOSED
DISPOSAL PRICE PER SHARE OF HANSA BIOPHARMA AB IS 42.2976 SEK
Source text: link
Further company coverage: HNSA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS